An exclusive opportunity to acquire a three-location outpatient physical therapy and balance-retraining portfolio in one of the fastest-growing healthcare submarkets in the top-ranked U.S. real estate metro. The offering includes the operating business of all three clinics, transferable franchise rights, and area rights for two additional protected territories.

Performance. Revenue has grown every year for four consecutive years: +33.2% (2023), +18.3% (2024), +25.8% (2025), with FY2026 tracking to approximately $1,100,000 on the basis of $451,920 in actual January–May 2026 collections. Trailing twelve-month collections are approximately $958,000. Accounts receivable have remained stable at roughly $249,000 across the growth period, confirming genuine volume expansion rather than billing lag. 2025 net income grew 28.4% on 19.5% revenue growth, and incremental revenue has converted at a demonstrated 45–50% flow-through.

Clinics. The flagship clinic (opened 2019, 1,983 SF, owner-held building) produced $656,500 in 2025 revenue — 26% above the $522,212 system franchisee average per Item 19 of the 2026 FDD — at a 38.9% location-level SDE margin, placing ownership among the system's top multi-unit operators. The second clinic (2023 build-out, 2,100 SF, third-party lease) is growing 25% annually and approaching breakeven. The third clinic (opened Q4 2025, 1,500 SF, owner-held building) is in its first full-year ramp. Combined footprint is 5,583 SF supporting approximately 9,410 patient visits in 2025 and roughly 11,800 projected for 2026.

Franchise system. The brand operates 500+ centers across 46 states plus 50 company-owned centers averaging $984,482 in revenue. The system provides national brand equity, clinical protocols in the high-margin balance and vestibular niche, payer-contracting support, and a proprietary resale channel. Royalties run approximately 5% of revenue. Transfer requires franchisor consent per the FDD.

Real estate. Two medical office properties (3,483 SF combined) are offered separately at $1,513,500, or the seller will retain them under 10–12 year absolute-NNN leasebacks at $28.00/SF. Pricing sits below new-construction replacement cost for Texas medical product. Real estate brokerage is conducted through Coldwell Banker under separate listing agreements.

Payer mix and demand. Approximately 60–70% Medicare, complemented by commercial insurance and patient-pay. The clinics serve physician-shortage-designated, high-income submarkets where roughly 65% of the metro's commercial development pipeline is concentrated.